Digestive & Intestinal Remedies (Pharmacies) - Malaysia

  • Malaysia
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$69.79m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 5.40%, resulting in a market volume of US$86.14m by 2028.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$2.01 are generated in 2024.

Key regions: United States, South Korea, Japan, Canada, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Malaysia is experiencing steady growth due to customer preferences for natural and herbal remedies, increasing awareness about digestive health, and a growing aging population.

Customer preferences:
Customers in Malaysia are increasingly opting for natural and herbal remedies for digestive and intestinal issues. This preference is driven by a growing awareness of the potential side effects of synthetic medications and a desire for more holistic approaches to healthcare. As a result, there is a rising demand for products made from natural ingredients such as ginger, peppermint, and aloe vera, which are believed to have digestive benefits.

Trends in the market:
The market for Digestive & Intestinal Remedies in Malaysia is witnessing a shift towards preventive care. Consumers are becoming more proactive in managing their digestive health and are seeking products that can prevent or alleviate common digestive issues such as indigestion, bloating, and constipation. This trend is driving the demand for products like probiotics, fiber supplements, and herbal teas that promote healthy digestion. Another trend in the market is the increasing popularity of online sales channels. With the rise of e-commerce platforms and the convenience of online shopping, more consumers are turning to online channels to purchase Digestive & Intestinal Remedies. This trend is particularly prominent among younger consumers who are tech-savvy and prefer the convenience of shopping from the comfort of their own homes.

Local special circumstances:
Malaysia has a diverse population with a mix of different ethnicities and cultures. This diversity is reflected in the variety of traditional remedies and practices for digestive health that are prevalent in the country. Traditional Malay, Chinese, and Indian medicine systems all have their own unique approaches to digestive health, and consumers in Malaysia often incorporate elements from these different traditions into their healthcare routines.

Underlying macroeconomic factors:
The growing aging population in Malaysia is a key driver of the Digestive & Intestinal Remedies market. As people age, they are more prone to digestive issues such as acid reflux, gastritis, and irritable bowel syndrome. This demographic shift is increasing the demand for products that can address these specific health concerns. Additionally, rising disposable incomes in Malaysia are enabling consumers to spend more on healthcare and wellness products. As people become more health-conscious and prioritize their well-being, they are willing to invest in products that can support their digestive health. In conclusion, the Digestive & Intestinal Remedies market in Malaysia is witnessing growth due to customer preferences for natural remedies, increasing awareness about digestive health, and the demographic shift towards an aging population. The market is also influenced by trends towards preventive care and the rise of online sales channels. The diverse cultural landscape in Malaysia further contributes to the demand for a variety of traditional remedies. Overall, the market is expected to continue growing as consumers prioritize their digestive health and seek out products that can support their well-being.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)